Verastem, Inc. Preferred Stock, Shares Issued
Verastem, Inc. (VSTM) had Preferred Stock, Shares Issued of 0 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Preferred Stock, Shares Issued 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Issued 0.00 shares.
- 2025-12-31: Preferred Stock, Shares Issued 0.00 shares.
- 2022-12-31: Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Issued as first filed 1.00M shares.
| Period end | Preferred Stock, Shares Issued | Preferred Stock, Shares Issued as first filed |
|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 0.00 shares 10-Q · filed 2026-05-07 | |
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-08-08 | 1.00M shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-09 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-14 | |
| 2021-09-30 | 0.00 shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-02 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-11 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-28 | |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-09 | |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 0.00 shares 10-K · filed 2021-03-18 | |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-10-30 | |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-01 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-11 | |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-07 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-03 | |
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-12 | |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-08 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-13 | |
| 2016-09-30 | 0.00 shares 10-Q · filed 2016-11-07 | |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-08 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-09 | |
| 2015-12-31 | 0.00 shares 10-K · filed 2017-03-23 | |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 0.00 shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 0.00 shares 10-K · filed 2016-03-03 | |
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-10-30 | |
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-08 | |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-10 | |
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-13 | |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2014-03-06 | |
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-13 | |
| 2012-03-31 | 0.00 shares 10-Q · filed 2012-05-14 | |
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |